
Adebrelimab in Small Cell Lung Cancer: From Current Advances to Emerging Combination Strategy and Challenge
Introduction Lung cancer is one of the most prevalent malignancies globally, with small cell lung cancer (SCLC) accounting for approximately 15% of all cases.1,2 As a type of neuroendocrine cancer, aggressive SCLC is characterized by hostile behavior, …